Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe

BACKGROUND: The importance of low-density lipoprotein cholesterol (LDL-C) lowering to reduce atherosclerotic cardiovascular disease (ASCVD) risk is strongly emphasized. If the LDL-C goals are not achieved with statin therapy, combination with ezetimibe is recommended. Studies revealed a substantial...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yinchu, Dong, Shujie, Shen, Peng, Sun, Yexiang, Lin, Hongbo, Zhai, Suodi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614052/
https://www.ncbi.nlm.nih.gov/pubmed/36312234
http://dx.doi.org/10.3389/fcvm.2022.988576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614052/
https://www.ncbi.nlm.nih.gov/pubmed/36312234
http://dx.doi.org/10.3389/fcvm.2022.988576

Ejemplares similares